HayandraLab

HayandraLab is an Indonesian biotechnology company and cGMP-certified laboratory specializing in regenerative medicine and cell therapy. Founded by Dr. Karina F. Moegni, the company focuses on the development and clinical application of autologous stem cells, stromal vascular fraction (SVF), and platelet-rich plasma (PRP). HayandraLab operates under the Yayasan Hayandra Peduli foundation and provides standardized cell processing services for various medical conditions, including wound healing, osteoarthritis, and degenerative diseases. The company is notable for its proprietary 'Hayandra Method' for SVF isolation and has conducted clinical trials for COVID-19 treatments using activated PRP. Its facilities are officially licensed by the Indonesian Ministry of Health for stem cell processing and clinical applications.